Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MET | P08581 | 5/20 | 0.47 |
| ▸ | MEN1 | O00255 | 3/20 | 0.39 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.39 |
| ▸ | CNR2 | P34972 | 1/20 | 0.39 |
| ▸ | PPARA | Q07869 | 1/20 | 0.39 |
| ▸ | TAS2R46 | P59540 | 3/20 | 0.38 |
| ▸ | PKM | P14618 | 2/20 | 0.38 |
| ▸ | RECQL | P46063 | 1/20 | 0.38 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.38 |
| ▸ | TERT | O14746 | 1/20 | 0.38 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | LMNA | P02545 | 4/20 | 0.33 |
| ▸ | TP53 | P04637 | 3/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.33 |
| ▸ | NLRP3 | Q96P20 | 2/20 | 0.33 |
| ▸ | NFKB1 | P19838 | 2/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.33 |
| ▸ | STAT6 | P42226 | 2/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Germacrene D SCHEMBL1164630 | 1.00 | MET (0.47) | METMEN1KMT2ACNR2PPARA | |
| Germacrene D SCHEMBL30105561 | 1.00 | MET (0.47) | METMEN1KMT2ACNR2PPARA | |
| Germacrene D SCHEMBL113144 | 1.00 | MET (0.47) | METMEN1KMT2ACNR2PPARA | |
| Germacrene D SCHEMBL2522883 | 1.00 | MET (0.47) | METMEN1KMT2ACNR2PPARA | |
| Germacrene D SCHEMBL29974910 | 1.00 | MET (0.47) | METMEN1KMT2ACNR2PPARA | |
| SCHEMBL30105602 | 0.98 | MET (0.49) | METMEN1KMT2ACNR2PPARA | |
| Beta-Phellandrene SCHEMBL154149 | 0.82 | MET (0.31) | MET | |
| Beta-Phellandrene SCHEMBL17629433 | 0.82 | MET (0.31) | MET | |
| Beta-Phellandrene SCHEMBL1306441 | 0.82 | MET (0.31) | MET | |
| Beta-Phellandrene SCHEMBL2531709 | 0.82 | MET (0.31) | MET |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1664 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3868206-B1 | A METHOD FOR THE HERBICIDAL TREATMENT OF DICOTYLEDONOUS WEEDS | RENDAPART (BE) | 2026-05-20 | — | — | EP | claimed |
| US-12540339-B2 | Germacrene synthase SgTPS7 protein, coding gene and use in synthesis of germacrene | RESEARCH INSTITUTE OF TROPICAL FORESTRY, CHINESE ACADEMY OF FORESTRY (CN) | 2026-02-03 | — | — | US | claimed |
| US-12514798-B2 | Use of [6]-paradol for stabilization of cosmetic compositions | SYMRISE AG (DE) | 2026-01-06 | — | — | US | claimed |
| EP-4646426-A1 | HOST CELLS CAPABLE OF PRODUCING SEQUITERPENOIDS AND METHODS OF USE THEREOF | Amyris, Inc. (US) | 2025-11-12 | — | — | EP | claimed |
| US-12446586-B2 | Oil-based insecticidal and insect repellent compositions | S. C. JOHNSON & SON, INC. (US) | 2025-10-21 | — | — | US | claimed |
| US-20250283119-A1 | FERMENTATION PROCESSES AND SYSTEMS | MANUS BIO INC (US) | 2025-09-11 | — | — | US | claimed |
| US-20250250591-A1 | GERMACRENE SYNTHASE SgTPS7 PROTEIN, CODING GENE AND USE IN SYNTHESIS OF GERMACRENE | RESEARCH INSTITUTE OF TROPICAL FORESTRY, CHINESE ACADEMY OF FORESTRY (CN) | 2025-08-07 | — | — | US | claimed |
| US-20250248400-A1 | NANOPARTICULATE FORMULATION FOR PREVENTING OR TREATING CALLOSE FORMATION IN PLANTS | PURDUE RESEARCH FOUNDATION (US) | 2025-08-07 | — | — | US | claimed |
| EP-4593977-A1 | PRODUCTS AND METHODS RELATED TO THE DISTILLATION OF MOLECULES FROM AEROSOLS | Natural Extraction Systems, LLC (US) | 2025-08-06 | — | — | EP | claimed |
| EP-4527191-A1 | UREASE INHIBITORS | Symrise AG (DE) | 2025-03-26 | — | — | EP | claimed |
| WO-2004028256-A1 | ATTRACTANT FOR APPLE FRUIT MOTH AND OTHER INSECT PESTS OF APPLE | FORSKARPATENT I SYD AB (SE) | 2004-04-08 | — | — | WO | claimed |
| EP-0918458-A4 | ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES | SQUIRES MERYL (US) | 2004-01-02 | — | — | EP | claimed |
| US-20030104082-A1 | Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases | MCGINLEY PARTNERS, LLC (US) | 2003-06-05 | — | — | US | claimed |
| US-20030099726-A1 | Antimicrobial treatment for herpes simplex virus and other infectious diseases | MCGINLEY PARTNERS, LLC (US) | 2003-05-29 | — | — | US | claimed |
| US-6355684-B1 | AQUEOUS BENZALKONIUM CHLORIDE, ECHINACEA AND ANTIMICROBIAL ISOLATES; VIRICIDES FOR PAPILLOMA, VARICELLA-ZOSTER, AND CYTOMEGALO VIRUSE; HIGH SPEED ANALGESIC; HEALING OF LESIONS; TOPICAL ADMINISTERING | Squires, Meryl J. | 2002-03-12 | — | — | US | claimed |
| EP-0980203-A1 | ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES | Squires, Meryl (US) | 2000-02-23 | — | — | EP | claimed |
| EP-0918458-A1 | ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES | Squires, Meryl (US) | 1999-06-02 | — | — | EP | claimed |
| WO-1998042188-A1 | ANTIMICROBIAL PREVENTION AND TREATMENT OF HUMAN IMMUNEDEFICIENCY VIRUS AND OTHER INFECTIOUS DISEASES | SQUIRES MERYL (US) | 1998-10-01 | — | — | WO | claimed |
| WO-1998011778-A1 | ANTIMICROBIAL TREATMENT FOR HERPES SIMPLEX VIRUS AND OTHER INFECTIOUS DISEASES | SQUIRES MERYL (US) | 1998-03-26 | — | — | WO | claimed |
| US-4089764-A | IRRADIATING AN ESSENTIAL OIL CONTAINING GERMACRENE D | THE LION DENTIFRICE CO., LTD. (JA) | 1978-05-16 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12540339-B2 | Germacrene synthase SgTPS7 protein, coding gene and use in synthesis of germacrene | GGPS1, FDPS, PTAR1 | MET 2479/4885MEN1 3597/4885KMT2A 3674/4885 |
| US-20030099726-A1 | Antimicrobial treatment for herpes simplex virus and other infectious diseases | KCNJ11, KCNJ1, TRPA1 | MET 3714/4885MEN1 2494/4885KMT2A 2269/4885 |
| US-20030104082-A1 | Antimicrobial prevention and treatment of human immunedeficience virus and other infectious diseases | CD14, CD59, SLC19A1 | MET 649/4885MEN1 492/4885KMT2A 3235/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.